Semi-Annual Consolidated Statement Of Cash Flows

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7600343

Concept 2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2020-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
17,387,000,000 JPY
19,521,000,000 JPY
Interest and dividends received
397,000,000 JPY
393,000,000 JPY
Interest paid
-17,000,000 JPY
-17,000,000 JPY
Net cash provided by (used in) operating activities
13,336,000,000 JPY
14,380,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,986,000,000 JPY
-1,973,000,000 JPY
Proceeds from sale of property, plant and equipment
704,000,000 JPY
874,000,000 JPY
Purchase of investment securities
JPY
-20,000,000 JPY
Proceeds from sale of investment securities
5,000,000 JPY
144,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-4,975,000,000 JPY
JPY
Other, net
-365,000,000 JPY
-357,000,000 JPY
Net cash provided by (used in) investing activities
-7,888,000,000 JPY
-1,644,000,000 JPY
Cash flows from financing activities
Dividends paid
-5,714,000,000 JPY
-5,811,000,000 JPY
Net cash provided by (used in) financing activities
-8,129,000,000 JPY
-8,752,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
JPY
JPY
Net increase (decrease) in cash and cash equivalents
-2,680,000,000 JPY
3,983,000,000 JPY
Cash and cash equivalents
74,625,000,000 JPY
77,305,000,000 JPY
73,322,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.